Physician

Andrew Spedding Calciano, MD

According to 2025 Medicare claims, Andrew Calciano, MD (NPI: 1942201702) practices dermatology in the Santa Cruz-Watsonville, CA market, with the plurality of this provider's patient population coming from Santa Cruz, CA. This provider's primary affiliated billing organization is FOREFRONT DERMATOLOGY - PACIFIC, P.C. (NPI: 1770361875; TIN: 770440158) and primary practice location at 95065-1709.

Calciano's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,854 traditional Medicare patients, billed 15,886 HCPCS/CPT codes, and received $924,408 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 1,381 prescription claims across 560 beneficiaries totaling $313,930 in drug costs, led by Taltz Autoinjector (Ixekizumab). Open Payments data shows 2 records totaling $146. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $97,324 to $313,930. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,251	12,146	$562,742
2016	1,361	12,623	$619,050
2017	1,582	14,713	$720,933
2018	1,527	15,032	$754,392
2019	1,566	15,125	$800,964
2020	1,383	13,616	$701,174
2021	1,474	14,453	$776,978
2022	1,595	14,400	$842,211
2023	1,656	14,508	$790,393
2024	1,854	15,886	$924,408

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	346	946	$97,324
2016	388	902	$61,346
2017	349	769	$51,585
2018	408	960	$86,453
2019	435	1,005	$155,812
2020	435	1,039	$217,274
2021	475	1,108	$237,560
2022	484	1,162	$333,539
2023	519	1,270	$261,237
2024	560	1,381	$313,930

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
11102	Biopsy of related skin growth, first growth	410	487	$77
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,163	1,851	$68
17000	Destruction of precancer skin growth, 1 growth	1,107	1,620	$45
88305	Pathology examination of tissue using a microscope, intermediate complexity	805	1,351	$31
17003	Destruction of precancer skin growth, 2-14 growths	947	6,591	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Taltz Autoinjector	Ixekizumab	12	372	$98,573
Dupixent Pen	Dupilumab	14	392	$51,130
Ivermectin	Ivermectin	22	622	$5,189
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	158	4,561	$4,504
Ketoconazole	Ketoconazole	219	6,888	$3,691

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$146	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrew Spedding Calciano, MD?

Tedicare shows public-source Medicare data for Andrew Spedding Calciano, MD (NPI 1942201702), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew Spedding Calciano, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Andrew Spedding Calciano, MD?

Andrew Spedding Calciano, MD is linked to FOREFRONT DERMATOLOGY - PACIFIC, P.C. (billing NPI 1770361875) in the available physician profile data.

Does Andrew Spedding Calciano, MD have Open Payments data?

Andrew Spedding Calciano, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.